OBJECTIVE: The authors' goal was to examine the frequency and type of obsessive and compulsive symptoms in Huntington's disease. METHOD: The Yale-Brown Obsessive Compulsive Scale was used to assess obsessive and compulsive symptoms in 27 patients with Huntington's disease. The neuropsychological test performance of the 14 patients with at least one obsessive symptom and the seven patients with at least one compulsive symptom was compared with the performance of the patients without such symptoms. RESULTS: More than half of the patients with Huntington's disease endorsed obsessive or compulsive symptoms on the Yale-Brown scale. Patients with obsessive or compulsive symptoms showed significantly greater impairment on neuropsychological tests measuring executive function than those without such symptoms. CONCLUSIONS: Basal ganglia pathology in Huntington's disease may contribute to production of obsessive and compulsive symptoms and to executive performance deficits in these patients.
OBJECTIVE: The authors' goal was to examine the frequency and type of obsessive and compulsive symptoms in Huntington's disease. METHOD: The Yale-Brown Obsessive Compulsive Scale was used to assess obsessive and compulsive symptoms in 27 patients with Huntington's disease. The neuropsychological test performance of the 14 patients with at least one obsessive symptom and the seven patients with at least one compulsive symptom was compared with the performance of the patients without such symptoms. RESULTS: More than half of the patients with Huntington's disease endorsed obsessive or compulsive symptoms on the Yale-Brown scale. Patients with obsessive or compulsive symptoms showed significantly greater impairment on neuropsychological tests measuring executive function than those without such symptoms. CONCLUSIONS: Basal ganglia pathology in Huntington's disease may contribute to production of obsessive and compulsive symptoms and to executive performance deficits in these patients.
Authors: Karen E Anderson; Carissa R Gehl; Karen S Marder; Leigh J Beglinger; Jane S Paulsen Journal: J Nerv Ment Dis Date: 2010-05 Impact factor: 2.254
Authors: H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Nathanael Hevelone; Steven M Hersch Journal: Ann N Y Acad Sci Date: 2008-12 Impact factor: 5.691
Authors: Heather H Wetzel; Carissa R Gehl; Lisa Dellefave-Castillo; Judith F Schiffman; Kathleen M Shannon; Jane S Paulsen Journal: Psychiatry Res Date: 2011-05-24 Impact factor: 3.222
Authors: Jason C Ehret; Patricia S Day; Ryan Wiegand; Joanne Wojcieszek; R Andrew Chambers Journal: Drug Alcohol Depend Date: 2006-08-22 Impact factor: 4.492
Authors: Juan Carlos Molano-Eslava; Angela Iragorri-Cucalón; Gonzalo Ucrós-Rodríguez; Carolina Bonilla-Jácome; Santiago Tovar-Perdomo; David V Herin; Luis Orozco-Cabal Journal: Rev Colomb Psiquiatr Date: 2008-10-01
Authors: Leigh J Beglinger; Jane S Paulsen; David B Watson; Chiachi Wang; Kevin Duff; Douglas R Langbehn; David J Moser; Henry L Paulson; Elizabeth H Aylward; Noelle E Carlozzi; Sarah Queller; Julie C Stout Journal: J Clin Psychiatry Date: 2008-09-09 Impact factor: 4.384
Authors: Karen Anderson; David Craufurd; Mary C Edmondson; Nathan Goodman; Mark Groves; Erik van Duijn; Daniel P van Kammen; Lavonne Goodman Journal: PLoS Curr Date: 2011-09-20